NCT05554276View on ClinicalTrials.gov

Neoadjuvant Chemotherapy Combined With PD-1 + Radical Radiotherapy in Locally Advanced Cervical Cancer

PHASE2RecruitingINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

August 1, 2023

Primary Completion Date

January 31, 2025

Study Completion Date

December 31, 2025

Conditions
Neoadjuvant ChemotherapyPD-1 AntibodyRadiotherapyCervical Cancer
Interventions
COMBINATION_PRODUCT

neoadjuvant chemotherapy combined with PD-1 antibody + radical radiotherapy

All patients received three cycles of 21 days each, with chemotherapy on day 1 (nab-paclitaxel 150 mg/m2 plus cisplatin 75 mg/m2) and camrelizumab 200 mg, followed by radical radiotherapy.

Trial Locations (1)

200233

RECRUITING

Vitalbeam, Shanghai

All Listed Sponsors
lead

Shanghai Jiao Tong University Affiliated Sixth People's Hospital

OTHER